It is markedly down-regulated in AH and liver cancer [7, 58–60], whereas hepatic production and serum CXCL1 and CXCL8 are highly elevated and correlated AH severity in humans [7, 51, 61–65]. The gene discussed is CXCL1; the disease is liver cancer.